Overview
Dr. Mackenzie Cervenka focuses on the diagnosis and treatment of patients with seizures and epilepsy, including surgical treatment and dietary therapies. She is an attending physician in the Epilepsy Monitoring Unit. Her specific interests include evaluations for seizure surgery, continuous electroencephalography in the intensive care unit, epilepsy in women (including considerations during pregnancy), and dietary therapies for adults with epilepsy. Dr. Cervenka's research focuses the efficacy of Ketogenic diets in the treatment of adults with epilepsy. She also studies brain mapping in preparation for epilepsy surgery. Dr. Cervenka completed her undergraduate studies at the University of Virginia and received her medical degree from the University of Virginia School of Medicine. She then completed her internship in internal medicine and residency in neurology at the University of Maryland Medical Center. Dr. Cervenka completed a fellowship in epilepsy and clinical neurophysiology at Johns Hopkins. Dr. Cervenka currently sees patients in The Johns Hopkins Outpatient Center on Monday and Wednesday afternoons. She also sees patients in The Johns Hopkins Adult Epilepsy Diet Center on Friday mornings once a month.
Dr. Cervenka is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Epilepsy, Seizures, Status Epilepticus, and Lennox-Gastaut Syndrome (LGS).
Her clinical research consists of co-authoring 86 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10753 Falls Road, Pavilion II STE 115, Pavilion II STE 115, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Johns Hopkins University
John Laterra is a Neurologist in Baltimore, Maryland. Dr. Laterra is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Laterra is currently accepting new patients.
University Of Maryland Neurology Associates PA
Haroon Ahmad is a Neurologist in Baltimore, Maryland. Dr. Ahmad is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Oligodendroglioma, Glioma, Astrocytoma, and Glioblastoma.
Johns Hopkins Outpatient Center
Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EpilepsyDr. Cervenka isElite. Learn about Epilepsy.
- SeizuresDr. Cervenka isElite. Learn about Seizures.
- Distinguished
- Lennox-Gastaut Syndrome (LGS)Dr. Cervenka isDistinguished. Learn about Lennox-Gastaut Syndrome (LGS).
- Status EpilepticusDr. Cervenka isDistinguished. Learn about Status Epilepticus.
- Advanced
- Absence SeizureDr. Cervenka isAdvanced. Learn about Absence Seizure.
- Generalized Tonic-Clonic SeizureDr. Cervenka isAdvanced. Learn about Generalized Tonic-Clonic Seizure.
- Landau-Kleffner SyndromeDr. Cervenka isAdvanced. Learn about Landau-Kleffner Syndrome.
- Memory LossDr. Cervenka isAdvanced. Learn about Memory Loss.
- Myoclonic EpilepsyDr. Cervenka isAdvanced. Learn about Myoclonic Epilepsy.
- Experienced
- Aicardi SyndromeDr. Cervenka isExperienced. Learn about Aicardi Syndrome.
- Alzheimer's DiseaseDr. Cervenka isExperienced. Learn about Alzheimer's Disease.
- AstrocytomaDr. Cervenka isExperienced. Learn about Astrocytoma.
- Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
- Autosomal Dominant Partial Epilepsy with Auditory Features
- Brain TumorDr. Cervenka isExperienced. Learn about Brain Tumor.